Akso Health Group ( HX) $ 2.24
-0.10 (-4.67 %)
| Symbol | HX |
| Price | $2.24 |
| Beta | 1.465 |
| Volume Avg. | $2.96 M |
| Market Cap | $160.11 M |
| 52 Week Range | $1.23 - $22.39 |
Akso Health Group opened the day at $2.24 which is -4.67 % on yesterday's close. Akso Health Group has a 52 week high of $22.39 and 52 week low of $1.23, which is a difference of $21.16. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $160.11 M and total net profit is $1754935 which means the company is trading at 91.24 times profit to market capitalization. Theoretically, if you were to buy Akso Health Group for $160.11 M, it would take 15 years to get your money back. Akso Health Group are in the Internet Retail space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
Akso Health Group Stock Forecast - Is Akso Health Group a Buy or Sell?
| DCF Score | Strong Buy | |
| ROE Score | Strong Sell | |
| ROA Score | Sell | |
| DE Score | Buy | |
| PE Score | Sell | |
| PB Score | Buy | |
| Overall Recommendation | Neutral |
Growth and Value
| PE Ratio | -0.362 |
| Dividend Yiel | 0.000 |
| Net Profit Margin | -4.661 |
Valuing Akso Health Group
| Price Book Value Ratio | 1.862 | Price To Book Ratio | 1.862 |
| Price To Sales Ratio | 1.687 | Price Earnings Ratio | -0.362 |
How liquid is Akso Health Group
| Current Ratio | 1.720 |
| Quick Ratio | 1.697 |
Debt
| Debt Ratio | 0.399 | Debt Equity Ratio | 0.663 |
| Long Term Debt To Capitalization | 0.000 | Total Debt To Capitalization | 0.000 |
Latest news about Akso Health Group
The stock price of Xiaobai Maimai Inc (NASDAQ: HX) increased by over 110% this past week. This is why it happened.
The stock price of Xiaobai Maimai Inc (NASDAQ: HX) increased by over 109% this past week. These are some details you should know.
BEIJING, July 28, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended March 31, 2021 with the U.S. Securities and Exchange Commission ("SEC") on July 28, 2021. The annual report on Form 20-F, which contains its audited financial statements, can be accessed on the SEC's website at http://www.sec.gov as well as via the Company's investor relations website at http://ir.xiaobaimaimai.com.
BEIJING, July 14, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced the appointment of Ms. Vivian Liu to its Board of Directors immediately, and that Ms.
BEIJING, March 11, 2021 /PRNewswire/ -- The "Social e-Commerce Enterprise Operational Service Standards" (the "Standards") was officially released by the Social e-Commerce Branch of China Association of Trade in Services (CATIS) in February 2021. Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai" or the "Company"), a social e-commerce platform in China, was one of the ten leading organizations that participated in the drafting of the Standards.
About Akso Health Group
Description :
Hexindai Inc. is a holding company, which engages in the operation of online marketplace connecting borrowers and investors. The company is headquartered in Beijing, Beijing and currently employs 552 full-time employees. The firm is focused on offering borrowers a range of products designed-based on customer segmentation data and tailored to the specific needs of the emerging middle class in China. The firm also offers five tailored loan products such as Provident Fund Loans, Property-Owner Loans, Car-Owner Loans, Insurance-Holder Loans, and Premier Customer Loans. The firm offers products and services to Borrowers, and Investors.
